Skip to content

ECO SCIENCE SOLUTIONS, INC.: 10-Q filed 2026-09-14

What ECO SCIENCE SOLUTIONS, INC. reported in its quarterly report filed 2026-09-14 (fiscal Q2 2027): 28 published measures, 82 facts as tagged in accession 0001477932-26-005573.

This filing

Form
10-Q (quarterly report)
Filed
2026-09-14
Fiscal period
fiscal Q2 2027
Accession
0001477932-26-005573 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ECO SCIENCE SOLUTIONS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2026-07-31105,334USD
At 2026-01-31170,824USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2026-07-311,673,389USD
At 2026-01-311,239,788USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2026-07-31-1,568,055USD
At 2026-04-30-1,311,741USD
At 2026-01-31-1,068,964USD
At 2025-07-31-17,098,536USD
At 2025-04-30-16,835,693USD
At 2025-01-31-16,562,272USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2026-05-01 to 2026-07-31-256,314USD92
2026-02-01 to 2026-07-31-499,091USD181
2025-05-01 to 2025-07-31-262,843USD92
2025-02-01 to 2025-07-31-536,264USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2026-02-01 to 2026-07-31-17,148USD181
2025-02-01 to 2025-07-31-162,482USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2026-05-01 to 2026-07-311,952USD92
2026-02-01 to 2026-07-312,205USD181
2025-05-01 to 2025-07-310USD92
2025-02-01 to 2025-07-310USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2026-02-01 to 2026-07-310USD181
2025-02-01 to 2025-07-31162,763USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2026-02-01 to 2026-07-310USD181
2025-02-01 to 2025-07-310USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2026-07-31-69,783,144USD
At 2026-01-31-69,284,053USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2026-05-01 to 2026-07-3124,952,656shares92
2026-02-01 to 2026-07-3124,952,656shares181
2025-05-01 to 2025-07-312,118,303shares92
2025-02-01 to 2025-07-312,118,303shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2026-05-01 to 2026-07-31-0.01USD/shares92
2026-02-01 to 2026-07-31-0.02USD/shares181
2025-05-01 to 2025-07-31-0.12USD/shares92
2025-02-01 to 2025-07-31-0.25USD/shares181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2026-05-01 to 2026-07-31-245,814USD92
2026-02-01 to 2026-07-31-478,043USD181
2025-05-01 to 2025-07-31-242,898USD92
2025-02-01 to 2025-07-31-497,193USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2026-07-3119,223USD
At 2026-01-3170,824USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2026-05-01 to 2026-07-3110,500USD92
2026-02-01 to 2026-07-3121,048USD181
2025-05-01 to 2025-07-319,807USD92
2025-02-01 to 2025-07-3119,295USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2026-07-311,673,389USD
At 2026-01-311,239,788USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2026-07-31841,270USD
At 2026-01-31712,189USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2026-07-3186,111USD
At 2026-01-31100,000USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2026-07-311,797USD
At 2026-01-310USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2026-05-01 to 2026-07-31247,766USD92
2026-02-01 to 2026-07-31480,248USD181
2025-05-01 to 2025-07-31242,898USD92
2025-02-01 to 2025-07-31497,193USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2026-05-01 to 2026-07-3178,705USD92
2026-02-01 to 2026-07-31140,738USD181
2025-05-01 to 2025-07-3180,053USD92
2025-02-01 to 2025-07-31178,770USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2026-07-3124,952,656shares
At 2026-01-3124,952,656shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2026-07-3115,551USD
At 2026-01-3132,699USD
At 2025-07-313,098USD
At 2025-01-312,817USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2026-07-3168,220,090USD
At 2026-01-3168,220,090USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2026-05-01 to 2026-07-31-256,314USD92
2026-02-01 to 2026-04-30-242,777USD89
2025-05-01 to 2025-07-31-262,843USD92
2025-02-01 to 2025-04-30-273,421USD89

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2026-05-01 to 2026-07-31-10,500USD92
2026-02-01 to 2026-07-31-21,048USD181
2025-05-01 to 2025-07-31-19,945USD92
2025-02-01 to 2025-07-31-39,071USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2026-02-01 to 2026-07-310USD181
2025-02-01 to 2025-07-310USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2026-02-01 to 2026-07-310USD181
2025-02-01 to 2025-07-310USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2026-02-01 to 2026-07-311,797USD181
2025-02-01 to 2025-07-310USD181

Inspect the source

Entity
ECO SCIENCE SOLUTIONS, INC. / CIK 0001490873
Captured
2026-09-20T09:10:04.551Z
SEC response SHA-256
82372196b8cfc3552e20c8eb11d91a9ba632552854c951fc5592d43a02c34a8d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001490873.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))